Second generation antipsychotics [1]

Psychopharmacology

Volumn 162, Issue 1, 2002, Pages 90-91

  Fleischhacker, W Wolfgang ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; SERTINDOLE;

AKATHISIA; CATALEPSY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG NOMENCLATURE; DRUG OVERDOSE; DRUG SAFETY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LETTER; LICENSING; PARKINSONISM; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; CLASSIFICATION; CLINICAL TRIAL; DYSKINESIA; METHODOLOGY; NOTE;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; DYSKINESIA, DRUG-INDUCED; HUMAN; HUMANS;

EID: 0035987563     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1064-8     Document Type: Letter

References (12)

1. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database
2. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
3. Atypical antipsychotics; an inspiring but confusing concept
4. Extrapyramidal side effects of clozapine and haloperidol
5. Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose
6. An atypical compound by any other name is still atypical
7. Non-equipotent doses explain differences among antipsychotics - Implications of PET studies
8. Atypical antipsychotics: Are some more atypical than others?
9. Constitution chimique et action pharmacologique d'un nouveau groupe de neuroleptiques tricycliques
10. Kritische stellungnahme zum begriff der neuroleptika
11. The usefulness and use of second generation antipsychotic medications
12. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia